23 completed, 1 unknown. 24 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 24 | Completed 23, Unknown 1 |
Follow bromfenac: new trials by email Literature Review of bromfenac trials Research Report on bromfenac
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Assessing eFficacy and Safety of DEXTENZA 0.4 mg inseRt, Following Cataract Surgery Dextenza 0.4Mg Ophthalmic Insert, Prednisolone Acetate 1% Oph Susp, Prolensa 0.07% Ophthalmic Solution - Corneal Edema, Corneal Defect | Phase 4 | Completed | Nicole Fram M.D. | 50 | 2023-06-01 | 2026-02-20 |
| Effects of Bromfenac on Macular Thickness After Phacoemulsification Surgery Bromfenac, Moxifloxacin 0.5% ophthalmic solution, Dexamethasone phosphate 0.1% - Cataract, Cystoid Macular Edema After Phacoemulsification | Phase 4 | Completed | Inas Abd | 87 | 2023-05-01 | 2025-05-06 |
| PCME Prevention in Patients With NPDR Bromfenac Ophthalmic 0.09% Ophthalmic Solution, Dexamethasone Ophthalmic, Placebo - Cystoid Macular Edema Following Cataract Surgery | Phase 4 | Completed | Klinički Bolnički Centar Zagreb | 90 | 2021-05-01 | 2022-05-20 |
| NSAID vs Steroid in Trabeculectomy Wound Management Bromfenac 0.07% Oph Susp, Dexamethasone - Glaucoma | Phase 4 | Unknown | Cindy Hutnik | 150 | 2020-11-01 | 2020-10-19 |
| Efficacy of Nonsteroidal Anti-Inflammatory Drugs for the Prevention of Cystoid Macular Edema Following Cataract Phacoemulsification Bromfenac 0.09 % Ophthalmic Solution, Nepafenac 0.1% eyedrops, diclofenac 0.1% ophthalmic susp. - Pseudophakic Cystoid Macular Edema | Phase 4 | Completed | Pomeranian Medical University Szczecin | 88 | 2020-10-14 | 2026-07-10 |
| A Prospective Clinical Study Evaluating Dexycu vs Prednisolone Acetate 1% Dexycu intracameral dexamethasone, Prednisolone Acetate - Cataract | Phase 4 | Completed | Research Insight LLC | 31 | 2019-12-16 | 2020-12-11 |
| Control of Pain in Intravitreal Injections Using Topical NSAIDs Bromfenac, Artificial tears - Intravitreal Injections, IVI | Phase 4 | Completed | University of Wisconsin, Madison | 46 | 2019-06-27 | 2023-06-12 |
| Prophylactic Treatment: Lessdrops™ vs Standard Drops Regimen Pred-Gati-Brom, Prednisolone acetate 1% ophthalmic suspension, Gatifloxacin Ophthalmic - Cataract | Phase 4 | Completed | Carolina Eyecare Physicians, LLC | 35 | 2018-06-22 | 2022-06-10 |
| Efficacy and Safety of PRO-155 on Inflammation of the Conjunctival Surface in Subjects With Grade I-III Pterygium vs Placebo. PRO-155, Placebo - Pterygium, Ocular Pain | Phase 4 | Completed | Laboratorios Sophia S.A de C.V. | 166 | 2017-12-13 | 2019-11-20 |
| Bromfenac Versus Dexamethasone After Cataract Surgery Bromfenac 0.09 % Ophthalmic Solution, Dexamethasone 0.1% ophthalmic suspension - Inflammation Eye | Phase 4 | Completed | Azienda USL Reggio Emilia - IRCCS | 92 | 2017-10-16 | 2025-06-25 |
| Effect of Bromfenac on Pain Related to Pterygium Surgery 0.1% bromfenac - Pterygium, Pain | Phase 4 | Completed | Zhongshan Ophthalmic Center, Sun Yat-sen University | 60 | 2016-10-01 | 2019-07-17 |
| Study Title: Clinical Outcomes of Prolensa (Bromfenac Ophthalmic Solution) 0.07% QD vs. Ilevro (Nepafenac Ophthalmic Suspension) 0.3% QD With Extra (Pulse) Dose on Day of Surgery for Treatment of Ocular Inflammation Associated With Cataract Surgery in a Randomized, Single Masked Clinical Trial Bromfenac, Nepafenac - Treatment of Ocular Inflammation Associated With Cataract Surgery | Phase 4 | Completed | Silverstein Eye Centers | 57 | 2013-10-30 | 2019-04-01 |
| Clinical Outcomes of Bromday (Bromfenac Ophthalmic Solution) 0.09% QD vs. Nevanac (Nepafenac Ophthalmic Suspension) 0.1% Bromfenac, Nepafenac - Inflammation, Pseudophakia | Phase 4 | Completed | Toyos Clinic | 23 | 2010-11-01 | 2020-10-28 |
| A Comparison of Prostaglandin E2 (PGE2) Inhibition of Acuvail(Ketorolac 0.45%), Xibrom (Bromfenac 0.09%)and Nevanac (Nepafenac)in Patients Undergoing Phacoemulsification Ketorolac Tromethamine, Bromfenac, nepafenac - Cataracts | Phase 4 | Completed | Frank A. Bucci, Jr., M.D. | 126 | 2009-10-01 | 2011-08-31 |
| A Comparison of Peak Aqueous Penetration of Acuvail (Ketorolac 0.45%), Xibrom (Bromfenac 0.09%), and Nevanac (Nepafenac 0.1%)in Patients Undergoing Phacoemulsification Ketorolac Tromethamine 0.45%, bromfenac 0.09%, nepafenac 0.1% - Cataracts | Phase 4 | Completed | Frank A. Bucci, Jr., M.D. | 126 | 2009-10-01 | 2011-10-03 |
| Evaluation of Comfort With Xibrom (Bromfenac Ophthalmic Solution)0.09% and Nevanac (Nepafenac Ophthalmic Suspension) 0.1% Following Selective Laser Trabeculoplasty (SLT) Xibrom, Nevanac - Intraocular Pressure | Phase 4 | Completed | Bp Consulting, Inc | 25 | 2009-01-01 | 2009-06-10 |
| Randomized, Double Blind Trial of Bromfenac BID (0.09%) as an Adjunct to Argon Laser Therapy in the Treatment of Diabetic Macular Edema. Bromefenac, Blink - Diabetic Macular Edema | Phase 4 | Completed | Bp Consulting, Inc | 50 | 2008-08-01 | 2009-09-04 |
| Determination of Optimum Duration of Treatment With Bromfenac (Xibrom) Eyedrops Following Cataract Surgery Bromfenac, Moxifloxacin hydrochloride, Prednisolone Acetate - Cataracts | Phase 4 | Completed | Bp Consulting, Inc | 49 | 2008-07-01 | 2012-03-15 |
| Comparing Optical Coherence Tomography (OCT) and Visual Acuity Outcomes in Subjects Undergoing Cataract Surgery, Who Receive Xibrom Ophthalmic Solution and Standard Presurgical Care vs. Xibrom Ophthalmic Solution Plus Prednisolone Acetate 1% and Standard Presurgical Care Xibrom, and Optive, Xibrom and Pred Forte - Cataracts | Phase 4 | Completed | Bp Consulting, Inc | 200 | 2008-06-01 | 2009-06-10 |
| Treatment of Acute Pseudophakic Cystoid Macular Edema: Bromfenac 0.09% Versus Diclofenac Sodium 0.1% Versus Ketorolac Tromethamine 0.5% Bromfenac, Ketorolac, Diclofenac - Acute Pseudophakic Cystoid Macular Edema | Phase 4 | Completed | Bp Consulting, Inc | 166 | 2008-01-01 | 2009-03-19 |
Showing 20 of 24. Sign in to see all of them.
Cataract (9) · Macular Edema (3) · Eye Pain (2) · Pain (2) · Pterygium (2) · Corneal Edema (1) · Dry Eye Syndromes (1) · Endophthalmitis (1) · Glaucoma (1) · Inflammation (1) · Pseudophakia (1)
Bp Consulting, Inc (5) · Frank A. Bucci, Jr., M.D. (2) · Innovative Medical (2) · Azienda USL Reggio Emilia - IRCCS (1) · Carolina Eyecare Physicians, LLC (1) · Center For Excellence In Eye Care (1) · Cindy Hutnik (1) · Florida Eye Microsurgical Institute (1) · Inas Abd (1) · Klinički Bolnički Centar Zagreb (1) · Laboratorios Sophia S.A de C.V. (1) · Nicole Fram M.D. (1) · Pomeranian Medical University Szczecin (1) · Research Insight LLC (1) · Silverstein Eye Centers (1)
United States (14) · China (1) · Croatia (1) · Iraq (1) · Italy (1) · Mexico (1) · Poland (1)
Andjela Jukic, MD, FEBO (1) · Barry Schechter, MD (1) · Carlos Buznego, MD (1) · Cindy Hutnik, MD (1) · David Rho, MD (1) · Frank A Bucci, Jr., MD (1) · Frank A Bucci, Jr.,, MD (1) · Frank Bucci, MD (1) · James Gills, MD (1) · Jeffrey Heier, MD (1) · John Hovanesian, MD (1) · Kerry Solomon, MD (1) · Luigi Fontana (1) · Marco Coassin, MD PhD (1)